Nanobiotix SA NBTX Q4 2025 Earnings Wide EPS Miss Stock Edges Higher on Clinical Progress FTK Q1 2026 Earnings EPS Misses Estimates Despite Slight Profit FPI Q1 2026 Earnings Earnings Per Share Misses Estimates Amid Seasonal Farmland Dynamics ERAS Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower TTRX Q1 2026 Earnings Narrow Loss Slightly Misses Estimates as PreRevenue Biotech Advances Pipeline ALX Q1 2026 Earnings EPS of 260 Reported Amid Modest Stock Decline Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues ALLT Q1 2026 Earnings Earnings Beat Expectations on Strong EPS Surprise SPS Commerce Q1 2026 Earnings EPS Surprises to the Upside as Operating Discipline Supports Bottom Line BSM Q1 2026 Earnings Significant EPS Miss Amid Weak Royalty Income VSECU Q1 2026 Earnings Strong EPS Surprise Drives Positive Stock Reaction ABM Q1 2026 Earnings EPS Misses Estimates Despite Operational Progress